TIAA CREF Investment Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$16.8M Buy
2018
Q4
$1.68M Sell
2018
Q3
$2.57M Buy
2018
Q2
$1.06M Buy
2018
Q1
$497K Sell
2017
Q4
$743K Sell
2017
Q3
$853K Buy
2017
Q2
$729K Buy
2017
Q1
$374K Sell
2016
Q4
$369K Sell
2016
Q3
$497 Hold
2016
Q2
$372K Buy